However, professional guidance places emphasis on establishing a genuine clinician-patient relationship rather than relying on questionnaire-only prescribing
If diet and exercise plans havent produced the results you were hoping for, GLP-1 therapy may help address the underlying biological factors involved
Its popularity is extending to teenagers and young adults, too, research out this week shows
Early Evidence In the latest GLP-1 study 2025 , orforglipron showed early promise for adults with obesity and those living with type 2 diabetes, especially at the highest evaluated dose
The rationale behind the formulation addresses three specific challenges that patients encounter during GLP-1 therapy: the appetite suppression and metabolic benefits of semaglutide, the muscle-preserving properties of glycine during rapid weight loss, and the nausea-reducing potential of B12 conjugation with GLP-1 receptor agonists
Quality varies